H. Jeffrey Wilkins
2021
In 2021, H. Jeffrey Wilkins earned a total compensation of $1.2M as Former Chief Medical Officer at Avalo Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,580 |
|---|---|
| Option Awards | $659,405 |
| Salary | $425,000 |
| Total | $1,249,985 |
Wilkins received $659.4K in option awards, accounting for 53% of the total pay in 2021.
Wilkins also received $165.6K in non-equity incentive plan and $425K in salary.
Rankings
In 2021, H. Jeffrey Wilkins' compensation ranked 7,973rd out of 12,412 executives tracked by ExecPay. In other words, Wilkins earned more than 35.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,973 out of 12,412 | 36th |
Division Manufacturing | 3,519 out of 5,498 | 36th |
Major group Chemicals And Allied Products | 1,564 out of 2,374 | 34th |
Industry group Drugs | 1,389 out of 2,095 | 34th |
Industry Pharmaceutical Preparations | 1,029 out of 1,542 | 33rd |
Source: SEC filing on April 25, 2022.
Wilkins' colleagues
We found four more compensation records of executives who worked with H. Jeffrey Wilkins at Avalo Therapeutics in 2021.